UPDATE: Benchmark Downgrades Vascular Solutions to Hold on Valuation

Benchmark downgraded Vascular Solutions VASC from Buy to Hold and announced a $17.00 price target. Benchmark commented, "We are downgrading Vascular Solutions to a Hold rating from a Buy rating based on valuation as VASC is trading close to our $17.00 price target. Our $17.00 price target represents 25 times our 2013 EPS estimate of $0.67. Our downgrade is purely based on valuation as we believe that VASC's core business remains strong and we remind investors that VASC has a strong balance sheet with cash of $11.5 million and no long-term debt." Vascular Solutions closed at $16.48 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorDowngradesAnalyst RatingsBenchmark
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!